SNY
Sanofi
Sanofi (SNY) is a global healthcare company with $113.6B market cap, showing a dominant political signal via $55.6M in 2024 doctor payments from Genzyme Corporation.
Govt Dependence
5/100
Regulatory Density
85/100
Lobbying Intensity
0/100
Political Signal
NEUTRAL
BusinessWhat SNY does
Sanofi is a multinational pharmaceutical company focused on prescription drugs, vaccines, and consumer healthcare. Revenue lines include specialty care (immunology, oncology), vaccines, and general medicines. The company operates through subsidiaries like Genzyme (specialty care) and Sanofi Pasteur (vaccines).
12 months past · 3 months futureSNY activity timeline
Congress
buy
sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened
+ added
− trimmed
closed
holds
Bills
past action (this ticker)
upcoming markup (sector)
★ carveout (this ticker)
248 trading days ·
5 congressional trades shown
·
0 insider buys
·
4 13F filings
·
3 past bill actions
·
3 upcoming markups
Lifetime Government AwardsSNY federal contracts by year
$1M
total awarded · 2011–2017
6
contracts on file
2011
peak year ($832K)
Top contracts by award amount
$832K
Department of Health and Human Serv
2011-07-30
M43298 ACCT 70004023 AVENTIS PASTEUR INC 08672328
$649K
Department of Health and Human Serv
2012-06-22
M45213 ACCOUNT 70004023 AVENTIS PASTEUR INC 08672328
$8K
Department of Defense
2012-11-16
YELLOW FEVER VAX
$7K
Department of Veterans Affairs
2012-05-07
PHARMACEUTICAL
$4K
Department of Veterans Affairs
2017-06-06
SEPRAFILM
7 years · 6 contracts
Smart Money · 13F HoldingsHedge funds holding SNY
$58.5M
Total SNY held by tracked 13F funds
2
Funds with SNY positions
Citadel Advisors
$52M
+78%
2025-12-31
Millennium Management
$7M
-90%
2025-12-31
Politicians Trading SNYMembers of Congress with recent SNY positions
2 politicians traded SNY across 11 disclosed transactions totaling $88K (last 730 days).
Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just SNY). 0-30 LOW · 30-60 MID · 60+ HIGH.
Congressional TradesWho in Congress is trading SNY
2025-09-11
Lisa C. McClain
sale
$1,001 - $15,000
2025-09-11
Lisa C. McClain
Sale
$1,001 - $15,000
2025-09-11
Lisa C. McClain
Sale (Full)
$1,001 - $15,000
2025-08-04
Lisa C. McClain
purchase
$1,001 - $15,000
2025-08-04
Lisa C. McClain
Purchase
$1,001 - $15,000
2025-07-22
Lisa C. McClain
Sale
$1,001 - $15,000
2025-06-17
Lisa C. McClain
purchase
$1,001 - $15,000
57d late
2025-07-22
Lisa C. McClain
sale
$1,001 - $15,000
2025-06-17
Lisa C. McClain
Purchase
$1,001 - $15,000
57d late
2024-09-04
John James
Sale
$1,001 - $15,000
2024-09-04
John James
sale
$1,001 - $15,000
2023-11-10
John James
purchase
$1,001 - $15,000
297d late
30+ trades on file · most recent 2025-10-22
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
No Form 4 activity recorded in the last 180 days.
Bills Affecting SNYLive legislation impacting this stock
S.827 · 119th
Supporting Rural Veterans Access to Healthcare Services Act
HR.2001 · 119th
Action for Dental Health Act
HR.1860 · 119th
Women Veterans Cancer Care Coordination Act
HR.2068 · 119th
Veterans Patient Advocacy Act
HR.2020 · 119th
New Mexico Rural Veteran Health Care Access Act
S.999 · 119th
Public Health Improvement Act
HR.2045 · 119th
Medicare Dental, Vision, and Hearing Benefit Act of 2025
HR.2062 · 119th
To amend the Internal Revenue Code of 1986 to treat membership in a health care sharing ministry as a medical expense, and for oth
HR.2048 · 119th
Metastatic Breast Cancer Access to Care Act
HR.2085 · 119th
Mental Health Research Accelerator Act of 2025
Political ProfileWhere SNY sits in Washington
[object Object]
STRUCTURAL: High regulatory density in healthcare sector and significant doctor payments ($55.6M in 2024) indicate exposure to policy changes. EVIDENTIARY: No federal contracts, lobbying spend, or corporate insider buys; one congressional trader (M001136) with mixed small trades. Net: Structural exposure without evidentiary support.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Physician payment transparency and potential scrutiny under Sunshine ActCMS"get_political_influence.doctor_payments shows $55.6M in 2024 payments from Genzyme Corporation"
Regulatory opportunities
-
Potential for vaccine contracts or reimbursement policiesHHS"get_political_influence.doctor_payments includes Sanofi Pasteur Inc. with $1.66M in 2024 payments"
Member intelligence layer
Live signals + predictions for SNY — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades SNY
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord
Frequently AskedAbout SNY & political exposure
Does Sanofi (SNY) hold federal contracts?
Yes. Sanofi has 6 federal contract awards totaling $1,498,639, primarily from agencies including Department of Defense, Department of Health and Human Services, Department of Veterans Affairs. See full contract list and amounts on this page.
Has Congress traded SNY stock?
57 congressional trades by 14 unique members of Congress, most recently on 2025-09-11. See the Congressional Trading panel for politician-by-politician breakdown.
What is SNY political risk profile?
Government dependence: 5/100. Lobbying intensity: 0/100. Political signal: neutral. Donor party split: R 0% / D 0%.
How does GovGreed track SNY political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. SNY data is updated daily from these official federal sources.